An international team of researchers have developed a new drug called covalent kinase inhibitor which they say, has potential to combat the spread of treatment-resistant malaria.
Trending
- Stakeholders demand speedy passage of bill to protect pangolins
- Kano invests N1bn on water supply system upgrade
- Nigeria needs dedicated centres to combat childhood cancer – Expert
- We can fund healthcare despite USAID’s exit – Pate
- FG dismisses Gambaryan’s ‘false allegations,’ says Binance offered $5m payment
- More women giving birth in public health facilities – Commissioner
- Vitamins B1, B6, and B12: The trio ultimate pain relievers
- Lagdo Dam: ECOWAS dismisses NGOs’ rights violation claims against Nigeria
